Array Biopharma Inc (NASDAQ:ARRY)

Tuesday’s Trading Day
8.05 -0.15 / -1.83%
As of Mar 03
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
8.10 +0.05 / +0.62%
 
Volume: 1.1K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. The company also discovers and develops drug candidates across a broad range of therapeutic areas in collaboration with leading pharmaceutical and biotechnology companies such as AstraZeneca, Novartis, InterMune and Roche. Array BioPharma was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Contact Information

Array BioPharma, Inc.
3200 Walnut Street
Boulder Colorado 80301
P:(303) 381-6600
Investor Relations:

Employees

Shareholders

Other institutional63.21%
Mutual fund holders31.82%
Individual stakeholders15.06%

Top Executives

Ron SquarerChief Executive Officer & Director
Andrew R. RobbinsChief Operating Officer
David J. HorinChief Financial Officer
Nick A. SaccomanoChief Scientific Officer
Robert E. WinklerVice President-Clinical Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account